Rchr
J-GLOBAL ID：201801019864400087
Update date: Jun. 20, 2023
Harigai Masayoshi
ハリガイ マサヨシ | Harigai Masayoshi
Contact this researcher
You can send email directly to the researcher.
Affiliation and department：
Tokyo Women's Medical University
About Tokyo Women's Medical University
Search "Tokyo Women's Medical University"
Detailed information
Papers (136)：
Takeuchi T, Harigai M, Tanaka Y, Yamanaka H, Ishiguro N, Yamamoto K, Miyasaka N, Koike T, Ukyo Y, Ishii Y, et al. Clinical efficacy, radiographic, and safety results of golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior therapy with disease-modifying antirheumatic drugs: Final results of the GO-MONO trial through week 120. Modern rheumatology. 2018. 28. 5. 770-779
Harigai M, Nagasaka K, Amano K, Bando M, Dobashi H, Kawakami T, Kishibe K, Murakawa Y, Usui J, Wada T, et al. 2017 Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of ANCA-associated vasculitis. Modern rheumatology. 2018. 1-11
Harigai M, Ishiguro N, Inokuma S, Mimori T, Ryu J, Takei S, Takeuchi T, Tanaka Y, Takasaki Y, Yamanaka H, et al. Safety and effectiveness of abatacept in Japanese non-elderly and elderly patients with rheumatoid arthritis in an all-cases post-marketing surveillance. Modern rheumatology. 2018. 29. 5. 1-23
Tanaka Y, Atsumi T, Amano K, Harigai M, Ishii T, Kawaguchi O, Rooney TP, Akashi N, Takeuchi T. Efficacy and safety of baricitinib in Japanese patients with rheumatoid arthritis: Subgroup analyses of four multinational phase 3 randomized trials. Modern rheumatology. 2018. 28. 4. 583-591
Nagasaka K, Harigai M, Hagino N, Hara A, Horita T, Hayashi T, Itabashi M, Ito S, Katsumata Y, Kawashima S, et al. Systematic Review and Meta-analysis for 2017 Clinical Practice Guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the Management of ANCA-associated Vasculitis. Modern rheumatology. 2018. 1-31
ｍore...
MISC (545)：
堤野 みち, 針谷 正祥. 【IL-6の発見と薬剤開発の歴史】 血管炎におけるIL-6のかかわり 発症の機序と治療標的としてのIL-6. Keynote R・A. 2018. 6. 1. 18-22
針谷 正祥. 「内科医・小児科医・病理医を招いた血管炎シンポジウム」 ANCA関連血管炎の診断・治療の進歩. 日本皮膚科学会雑誌. 2018. 128. 5. 863-863
有村 義宏, 針谷 正祥, 丸山 彰一, 本間 栄. 診療ガイドラインat a glance ANCA関連血管炎診療ガイドライン2017. 日本内科学会雑誌. 2018. 107. 4. 741-745
要 伸也, 針谷 正祥. 難治性血管炎に関する調査研究班の研究成果と課題. 日本腎臓学会誌. 2018. 60. 3. 312-312
長坂 憲治, 佐田 憲映, 駒形 嘉紀, 堤野 みち, 針谷 正祥, 有村 義宏. 血管炎診療の最前線 MPA、GPAに対するリツキシマブ治療 RemIRIT研究から. 日本リウマチ学会総会・学術集会プログラム・抄録集. 2018. 62回. 272-272
ｍore...
Awards (1)：
Japan College of Rheumatology Japan College of Rheumatology Award
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM
